Literature DB >> 21042899

Risk stratification in diabetes: not all patients or perfusion defects are the same.

Lawrence H Young.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 21042899     DOI： 10.1007/s12350-010-9306-3

Source DB:  PubMed          Journal:  J Nucl Cardiol        ISSN： 1071-3581            Impact factor:   5.952


× No keyword cloud information.
  7 in total

1.  Influence of diabetes on 5-year mortality and morbidity in a randomized trial comparing CABG and PTCA in patients with multivessel disease: the Bypass Angioplasty Revascularization Investigation (BARI)

Authors: 
Journal:  Circulation       Date:  1997-09-16       Impact factor: 29.690

2.  Predictors of mortality and mortality from cardiac causes in the bypass angioplasty revascularization investigation (BARI) randomized trial and registry. For the BARI Investigators.

Authors:  M M Brooks; R H Jones; R G Bach; B R Chaitman; M J Kern; T A Orszulak; D Follmann; G Sopko; E H Blackstone; R M Califf
Journal:  Circulation       Date:  2000-06-13       Impact factor: 29.690

3.  Duration and type of therapy for diabetes: impact on cardiac risk stratification with stress electrocardiographic-gated SPECT myocardial perfusion imaging.

Authors:  Dimitrios Barmpouletos; Gerasimos Stavens; Alan W Ahlberg; Deborah M Katten; David M O'Sullivan; Gary V Heller
Journal:  J Nucl Cardiol       Date:  2010-10-21       Impact factor: 5.952

4.  Detection of silent myocardial ischemia in asymptomatic diabetic subjects: the DIAD study.

Authors:  Frans J Th Wackers; Lawrence H Young; Silvio E Inzucchi; Deborah A Chyun; Janice A Davey; Eugene J Barrett; Raymond Taillefer; Steven D Wittlin; Gary V Heller; Neil Filipchuk; Samuel Engel; Robert E Ratner; Ami E Iskandrian
Journal:  Diabetes Care       Date:  2004-08       Impact factor: 19.112

5.  Effects of intensive glucose lowering in type 2 diabetes.

Authors:  Hertzel C Gerstein; Michael E Miller; Robert P Byington; David C Goff; J Thomas Bigger; John B Buse; William C Cushman; Saul Genuth; Faramarz Ismail-Beigi; Richard H Grimm; Jeffrey L Probstfield; Denise G Simons-Morton; William T Friedewald
Journal:  N Engl J Med       Date:  2008-06-06       Impact factor: 91.245

6.  Cardiac outcomes after screening for asymptomatic coronary artery disease in patients with type 2 diabetes: the DIAD study: a randomized controlled trial.

Authors:  Lawrence H Young; Frans J Th Wackers; Deborah A Chyun; Janice A Davey; Eugene J Barrett; Raymond Taillefer; Gary V Heller; Ami E Iskandrian; Steven D Wittlin; Neil Filipchuk; Robert E Ratner; Silvio E Inzucchi
Journal:  JAMA       Date:  2009-04-15       Impact factor: 56.272

7.  The significant effect of diabetes duration on coronary heart disease mortality: the Framingham Heart Study.

Authors:  Caroline S Fox; Lisa Sullivan; Ralph B D'Agostino; Peter W F Wilson
Journal:  Diabetes Care       Date:  2004-03       Impact factor: 19.112
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.